Previous
Paris Saint-Germain
Stade Rennes
6:30 PM UTC
Game Details
Sporting Gijón
Eibar
6:30 PM UTC
Game Details
FC Augsburg
FC Cologne
6:30 PM UTC
Game Details
Birmingham City
Middlesbrough
6:45 PM UTC
Game Details
New York Red Bulls
FC Dallas
11:00 PM UTC
Game Details
Querétaro
Pumas UNAM
12:30 AM UTC Apr 30, 2016
Game Details
Tijuana
Puebla
2:30 AM UTC Apr 30, 2016
Game Details
Next

Trending: Wenger blames pundits for unrest

Latest
Read

Huntelaar taken off Schalke penalty duty

Schalke
Read
Bayer LeverkusenBayer Leverkusen
Hertha BerlinHertha Berlin
4:30 PM UTC
Game Details
Borussia DortmundBorussia Dortmund
VfL WolfsburgVfL Wolfsburg
1:30 PM UTC
Game Details

Sammer: No 'exact prognosis' over Thiago Alcantara Bayern return

Bayern Munich and Spain midfielder Thiago Alcantara's return date from a serious knee injury remains unclear, according to the German club's sporting executive Matthias Sammer.

Thiago, 23, tore a ligament in his right knee in late March against Hoffenheim and was initially ruled out for six to eight weeks. However, the former Barcelona starlet suffered a setback and needed to undergo a second surgery in May, only two days after returning to the squad, and has not played since -- missing out of the World Cup with Spain.

"We can't respectably say how long this will take. We can't give an exact prognosis," Sammer told kicker. "The development is very regrettable." 

Reports had suggested that Thiago could be back in team training as early as September but, on Thursday, kicker called that date "utopian."

Kicker also reported that Thiago's cortisone injection treatment in Barcelona has become a touchy subject between manager Pep Guardiola, who opted for treatment in Spain, and club doctor Muller-Wohlfahrt, who is against such treatment.

Comments

Use a Facebook account to add a comment, subject to Facebook's Terms of Service and Privacy Policy. Your Facebook name, photo & other personal information you make public on Facebook will appear with your comment, and may be used on ESPN's media platforms. Learn more.